These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32388275)

  • 1. Internalization and antigen presentation by mouse dendritic cells of rotavirus VP6 preparations differing in nanostructure.
    Tamminen K; Heinimäki S; Gröhn S; Blazevic V
    Mol Immunol; 2020 Jul; 123():26-31. PubMed ID: 32388275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
    Malm M; Heinimäki S; Vesikari T; Blazevic V
    Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo.
    Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    J Immunol Res; 2020; 2020():3194704. PubMed ID: 32411793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
    Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.
    Blazevic V; Malm M; Arinobu D; Lappalainen S; Vesikari T
    Hum Vaccin Immunother; 2016 Mar; 12(3):740-8. PubMed ID: 26467630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
    Lappalainen S; Tamminen K; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding internalization of rotavirus VP6 nanotubes by cells: towards a recombinant vaccine.
    Rodríguez M; Wood C; Sanchez-López R; Castro-Acosta RM; Ramírez OT; Palomares LA
    Arch Virol; 2014 May; 159(5):1005-15. PubMed ID: 24232915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
    Li T; Lin H; Zhang Y; Li M; Wang D; Che Y; Zhu Y; Li S; Zhang J; Ge S; Zhao Q; Xia N
    Vaccine; 2014 Apr; 32(17):1921-31. PubMed ID: 24530406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies.
    Saldaña S; Esquivel Guadarrama F; Olivera Flores Tde J; Arias N; López S; Arias C; Ruiz-Medrano R; Mason H; Mor T; Richter L; Arntzen CJ; Gómez Lim MA
    Viral Immunol; 2006; 19(1):42-53. PubMed ID: 16553549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
    Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
    Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
    Dennehy M; Bourn W; Steele D; Williamson AL
    Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.
    Garaicoechea L; Olichon A; Marcoppido G; Wigdorovitz A; Mozgovoj M; Saif L; Surrey T; Parreño V
    J Virol; 2008 Oct; 82(19):9753-64. PubMed ID: 18632867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model.
    Temprana CF; Argüelles MH; Gutierrez NM; Barril PA; Esteban LE; Silvestre D; Mandile MG; Glikmann G; Castello AA
    PLoS One; 2018; 13(9):e0203700. PubMed ID: 30192869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles.
    Malm M; Tamminen K; Lappalainen S; Vesikari T; Blazevic V
    J Immunol Res; 2016; 2016():9171632. PubMed ID: 27689099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery.
    Zhao Q; Chen W; Chen Y; Zhang L; Zhang J; Zhang Z
    Bioconjug Chem; 2011 Mar; 22(3):346-52. PubMed ID: 21338097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
    Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein.
    Bugli F; Caprettini V; Cacaci M; Martini C; Paroni Sterbini F; Torelli R; Della Longa S; Papi M; Palmieri V; Giardina B; Posteraro B; Sanguinetti M; Arcovito A
    Int J Nanomedicine; 2014; 9():2727-39. PubMed ID: 24936129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in
    Malm M; Diessner A; Tamminen K; Liebscher M; Vesikari T; Blazevic V
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31083495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.